{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:02:21Z","timestamp":1792839741815,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100009232","name":"University of Debrecen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009232","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10620-025-09033-8","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T14:56:46Z","timestamp":1744297006000},"page":"2467-2474","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long Term Follow-Up of Patients with Cryoglobulinemia After Successful Treatment of Chronic C Virus Hepatitis"],"prefix":"10.1007","volume":"70","author":[{"given":"Bianka Zsuzsa","family":"Elthes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Vitalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Tornai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Tornai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istvan","family":"Tornai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"9033_CR1","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/hep.26141","volume":"57","author":"K Mohd Hanafiah","year":"2013","unstructured":"Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57:1333\u20131342.","journal-title":"Hepatology."},{"key":"9033_CR2","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/hep.27950","volume":"62","author":"AASLD\/IDSA HCV Guidance Panel","year":"2015","unstructured":"AASLD\/IDSA HCV Guidance Panel. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology. 2015;62:932\u2013954.","journal-title":"Hepatology."},{"key":"9033_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/M13-1133","volume":"160","author":"MM Denniston","year":"2014","unstructured":"Denniston MM, Jiles RB, Drobeniuc J et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med. 2014;160:293\u2013300.","journal-title":"Ann Intern Med."},{"key":"9033_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.14218\/JCTH.2018.00049","volume":"7","author":"L Kuna","year":"2019","unstructured":"Kuna L, Jakab J, Smolic R et al. HCV Extrahepatic Manifestations. J Clin Transl Hepatol. 2019;7:172\u2013182.","journal-title":"J Clin Transl Hepatol."},{"key":"9033_CR5","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1056\/NEJMra2400092","volume":"391","author":"P Cacoub","year":"2024","unstructured":"Cacoub P, Vieira M. Saadoun D Cryoglobulinemia-One Name for Two Diseases. N Engl J Med. 2024;391:1426\u20131439.","journal-title":"N Engl J Med."},{"key":"9033_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12016-013-8390-y","volume":"47","author":"J Damoiseaux","year":"2014","unstructured":"Damoiseaux J, Tervaert JWC. Diagnostics and Treatment of Cryoglobulinemia: It Takes Two to Tango. Clin Rev Allergy Immunol. 2014;47:299\u2013310.","journal-title":"Clin Rev Allergy Immunol."},{"key":"9033_CR7","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJMra2033539","volume":"384","author":"P Cacoub","year":"2021","unstructured":"Cacoub P, Saadoun D. Extrahepatic manifestations of chronic HCV infection. N Engl J Med. 2021;384:1038\u20131052.","journal-title":"N Engl J Med."},{"key":"9033_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1001\/archinte.165.1.101","volume":"165","author":"G Monti","year":"2005","unstructured":"Monti G, Pioltelli P, Saccardo F et al. Incidence and Characteristics of Non-Hodgkin Lymphomas in a Multicenter Case File of Patients With Hepatitis C Virus-Related Symptomatic Mixed Cryoglobulinemias. Arch Intern Med. 2005;165:101\u2013105.","journal-title":"Arch Intern Med."},{"key":"9033_CR9","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1158\/1055-9965.EPI-06-0308","volume":"15","author":"L Dal Maso","year":"2006","unstructured":"Dal Maso L, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev. 2006;15:2078\u20132085.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"9033_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.cmi.2019.06.018","volume":"26","author":"YT Cheng","year":"2020","unstructured":"Cheng YT, Cheng JS, Lin CH, Chen TH, Lee KC, Chang ML. Rheumatoid factor and immunoglobulin M mark hepatitis C-associated mixed cryoglobulinemia: an 8-year prospective study. Clin Microbiol Infect. 2020;26:366\u2013372.","journal-title":"Clin Microbiol Infect."},{"key":"9033_CR11","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1053\/j.gastro.2017.02.037","volume":"152","author":"C Comarmond","year":"2017","unstructured":"Comarmond C, Garrido M, Pol S et al. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis. Gastroenterology. 2017;152:2052-2062.e2.","journal-title":"Gastroenterology."},{"key":"9033_CR12","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/liv.14053","volume":"39","author":"M Visentini","year":"2019","unstructured":"Visentini M, Del Padre M, Colantuono S et al. Long-lasting persistence of large B-cell clones in hepatitis C virus-cured patients with complete response of mixed cryoglobulinaemia vasculitis. Liver Int. 2019;39:628\u2013632.","journal-title":"Liver Int."},{"key":"9033_CR13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.cgh.2018.05.021","volume":"17","author":"P Cacoub","year":"2019","unstructured":"Cacoub P, Si Ahmed SN, Ferfar Y et al. Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis. Clin Gastroenterol Hepatol. 2019;17:518\u2013526.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9033_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1053\/j.gastro.2018.04.024","volume":"155","author":"M Bonacci","year":"2018","unstructured":"Bonacci M, Lens S, Mari\u00f1o Z et al. Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure. Gastroenterology. 2018;155:311-315.e6.","journal-title":"Gastroenterology."},{"key":"9033_CR15","doi-asserted-by":"publisher","first-page":"627","DOI":"10.14309\/ajg.0000000000001667","volume":"117","author":"A Fayed","year":"2022","unstructured":"Fayed A, Hegazy MT, Biard L et al. Relapse of Hepatitis C Virus Cryoglobulinemic Vasculitis After Sustained Viral Response After Interferon-Free Direct-Acting Antivirals. Am J Gastroenterol. 2022;117:627\u2013636.","journal-title":"Am J Gastroenterol."},{"key":"9033_CR16","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/clinchem\/38.6.798","volume":"38","author":"L Musset","year":"1992","unstructured":"Musset L, Diemert MC, Taibi F et al. Characterisation of cryoglobulins by immunoblotting. Clin Chem. 1992;38:798\u2013802.","journal-title":"Clin Chem."},{"key":"9033_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.pathol.2022.09.004","volume":"55","author":"A Stoyanov","year":"2023","unstructured":"Stoyanov A, Toong C, Kong Y, Chen R, Urriola N. Serum protein electrophoresis and rheumatoid factor analysis is an effective screening strategy for cryoglobulinaemia. Pathology 2023;55:391\u2013396.","journal-title":"Pathology"},{"key":"9033_CR18","first-page":"1775","volume":"30","author":"C Mazzaro","year":"2003","unstructured":"Mazzaro C, Zorat F, Comar C et al. Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon. J Rheumatol 2003;30:1775\u20131781.","journal-title":"J Rheumatol"},{"key":"9033_CR19","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1002\/art.10699","volume":"46","author":"P Cacoub","year":"2002","unstructured":"Cacoub P, Lidove O, Maisonobe T et al. Interferon-\u03b1 and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum. 2002;46:3317\u20133326.","journal-title":"Arthritis Rheum."},{"key":"9033_CR20","first-page":"933","volume":"29","author":"C Mazzaro","year":"2011","unstructured":"Mazzaro C, Monti G, Saccardo F et al. Efficacy and safety of peginterferon alfa-2b plus ribavirin for HCV-positive mixed cryoglobulinemia: a multicentre open-label study. Clinical and Experimental Rheumatology. 2011;29:933\u2013941.","journal-title":"Clinical and Experimental Rheumatology."},{"key":"9033_CR21","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/hep.27623","volume":"61","author":"L Gragnani","year":"2015","unstructured":"Gragnani L, Fognani E, Piluso A, MaSVE Study Group et al. Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study. Hepatology. 2015;61:1145\u20131153.","journal-title":"Hepatology."},{"key":"9033_CR22","doi-asserted-by":"publisher","first-page":"102589","DOI":"10.1016\/j.autrev.2020.102589","volume":"19","author":"C Mazzaro","year":"2020","unstructured":"Mazzaro C, Dal Maso L, Mauro E et al. Hepatitis C virus- related cryoglobulinemic vasculitis: A review of the role of the new direct antiviral agents (DAAs) therapy. Autoimmun Rev. 2020;19:102589.","journal-title":"Autoimmun Rev."},{"key":"9033_CR23","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/hep.28297","volume":"63","author":"ME Sise","year":"2016","unstructured":"Sise ME, Bloom AK, Wisocky J et al. Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents. Hepatology. 2016;63:408\u2013417.","journal-title":"Hepatology."},{"key":"9033_CR24","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/hep.28753","volume":"64","author":"L Gragnani","year":"2016","unstructured":"Gragnani L, Visentini M, Fognani E et al. Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia. Hepatology. 2016;64:1473\u20131482.","journal-title":"Hepatology."},{"key":"9033_CR25","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cgh.2016.09.158","volume":"15","author":"M Bonacci","year":"2017","unstructured":"Bonacci M, Lens S, Londo\u00f1o MC et al. Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus-Associated Cryoglobulinemia Treated With Direct-Acting Antivirals. Clin Gastroenterol Hepatol. 2017;15:575-583.e1.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9033_CR26","doi-asserted-by":"publisher","first-page":"175628482094261","DOI":"10.1177\/1756284820942617","volume":"13","author":"C Comarmond","year":"2020","unstructured":"Comarmond C, Cacoub P, Saadoun D. Treatment of chronic hepatitis C-associated cryoglobulinemia vasculitis at the era of direct-acting antivirals. Therap Adv Gastroenterol. 2020;13:1756284820942617.","journal-title":"Therap Adv Gastroenterol."},{"key":"9033_CR27","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1007\/s10620-020-06507-9","volume":"66","author":"ML Chang","year":"2021","unstructured":"Chang ML, Hu JH, Chen WT, Lin MS, Kuo CJ, Chen SC, Chien RN. Interactive Impacts from Hepatitis C Virus Infection and Mixed Cryoglobulinemia on Complement Levels. Dig Dis Sci. 2021;66:2407\u20132416. https:\/\/doi.org\/10.1007\/s10620-020-06507-9.","journal-title":"Dig Dis Sci."},{"key":"9033_CR28","doi-asserted-by":"publisher","first-page":"823160","DOI":"10.3389\/fimmu.2022.823160","volume":"13","author":"ML Chang","year":"2022","unstructured":"Chang ML, Cheng JS, Chuang YH et al. Evolution of Cryoglobulinemia in Direct-Acting Antiviral-Treated Asian Hepatitis C Patients With Sustained Virological Responses: A 4-Year Prospective Cohort Study. Front Immunol. 2022;13:823160.","journal-title":"Front Immunol."},{"key":"9033_CR29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/hep.32281","volume":"76","author":"LA Kondili","year":"2022","unstructured":"Kondili LA, Monti M, Quaranta MG et al. A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort. Hepatology. 2022;76:220\u2013232.","journal-title":"Hepatology."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09033-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09033-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09033-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T10:50:51Z","timestamp":1757155851000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09033-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["9033"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09033-8","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study design was approved by the Regional and Institutional Research Ethics Committee (RKEB\/IKEB 5306-9\/2011). All patients gave their consent to this prospective trial and all investigations were in line with the declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}